Venous thromboembolism (VTE) is a major cause of maternal morbidity and mortality. The estimated incidence of VTE during pregnancy and the postpartum period is 1 to 2 per 1,000 deliveries.1 The risk of VTE is particularly high during the postpartum period and especially following cesarean delivery. There is considerable variation in the approach to VTE prophylaxis in preg-nancy, including following cesarean delivery. Recent guidelines by various profes-sional organizations provide conflicting recommendations based on low-grade evidence, mainly from observational data. At present, the available VTE risk strati-fication tools used to decide for or against pharmacological prophyla☓is have not been validated in women undergoing cesarean delivery. Individualization of care is recommended for women at very high risk of VTE.
|Original language||English (US)|
|Number of pages||5|
|State||Published - Oct 2020|
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Maternity and Midwifery
- Advanced and Specialized Nursing